Community Pharmacy Local Enhanced

Service Agreement

Provision of Chlamydia Screening

2010/11

Version: Final v. 18.11.2010

Date Reviewed by LPC: November 2010

Responsible

Clinician/Service Lead: Vivien Thompson

Responsible

Commissioning Manager: Julie M Howard

Review date: March 2011

COMMUNITY PHARMACY LOCAL ENHANCED SERVICE AGREEMENT 2010/2011

Provision of Chlamydia Screening

Contents

1Introduction

2Background

3Service Aims

4Service Outline

5Service Expectations

6Eligibility to provide the service

7Quality & Clinical Governance Standards

8Information & Data Collection Requirements

9Performance Management

10Exit and Suspension Arrangements

11Activity & Costs

12References

13Signatures

14Appendices:

  1. Fraser Guidelines

1Introduction

All Providers are expected to provide Essential and those Additional services that they are contracted to provide to all theirpatients. This Local CommunityPharmacy Enhanced Service (CPLES) Agreement outlines the more specialised service to be provided. The specification of this service is designed to cover the enhanced aspects of clinical care of the patient, all of which are beyond the scope of Essential Services. No part of the specification by commission, omission or implication defines or redefines Essential or Additional Services.

2Background

Genital Chlamydiatrachomatis is the most common sexually transmitted infection (STI) in the UK and affecting over 8% of screened General Practice populations in Chlamydia screening pilots. Chlamydia is currently the commonest curable sexually transmitted infection in England.

Infection is commonly asymptomatic (70% women and 50% men).The consequences of Chlamydia infection can be severe, particularly for women in whom infection may lead to pelvic inflammatory disease, ectopic pregnancy, tubal factor infertility and chronic abdominal pain.

Community Pharmacies offer a convenient, easily accessible location for people wanting information, screening for Chlamydia, especially in areas of social deprivation and high health need.

3Service Aims

The aim of this Community Pharmacy Local Enhance Service (CPLES) is to:

To increase knowledge and awareness especially among young people of the National Chlamydia Screening Programme, whereabouts of screening facilities and the availability of treatment for Chlamydia.

To increase the uptake of screening for Chlamydia by young people who have had unprotected sex and/or a new partner, and thus help contribute to a reduction in the prevalence of the infection and its medical complications

To reduce burden on secondary care services by diagnosing infections in the community.

To de-stigmatise Chlamydia infection and raise awareness of safer sexual practices

The specific objectives of this CPLES are to:

  • Improve access to ‘self administrated’ screening kits
  • Promote the use of screening kits and increase the number of test samples returned for analysis

4Service Outline

The pharmacy contractor has a duty to ensure that pharmacists involved in the provision of the service are aware of and operate within local protocols.

On occasions pharmacists may need to share relevant information with other health care professionals and agencies, in line with local and national confidentiality and data protection arrangements, including the need for the permission of the person to share the information.

The PCT will provide up to date details of other services to which people that require further assistance can be referred. The information will include the location, hours of opening and services provided by each service provider.

Eligibility criteria and referral pathways for this service are agreed locally with the PCT.

The PCT provide a framework for the recording of relevant service information for the purposes of audit and the claiming of payment.

Relevant patient information leaflets will be provided to pharmacies delivering this service by the PCT.

At least one meeting per year will be arranged by the PCT to promote service development and update pharmacy staff with new developments, knowledge and evidence.

5Service Expectations

Participating Community Pharmacy staff will promote the use of, and supply of free ‘self administration’ Chlamydia screening kits to appropriate patients aged under 25 years old.

The Wakefield District Chlamydia Screening Programme will undertake all treatment and partner notification procedures

Community Pharmacies will offer a patient-focused, easily accessible, non-judgmental and confidential service.

If appropriate, community pharmacies will provide information about other local sexual health screening, treatment and advice services.

6Eligibility to provide the service

Participating pharmacies must notify the commissioner if there are any changes in accreditation.

7Hours of service and continuity

The service should be provided during the registered core and supplementary hours of the pharmacy.

If this is not possible e.g. in the absence of the accredited pharmacist or other accredited staff member, the pharmacy staff will signpost the client to another pharmacy that is able to provide the service and should whenever possible phone to check that the services is available at a time suitable to the patient.

8Eligibility to provide the service

Prior to selection for engagement in this service community pharmacies must be capable of delivering all of the essential services of the Community Pharmacy Contract as set out by the National Health Service (Pharmaceutical Regulations) 2005 (Department of Health [DH] 2005).

The pharmacy contractor has a duty to ensure that all pharmacy staff involved in the provision of the service have the relevant knowledge and are appropriately trained in the operation of the service, including sensitive, client-centred communication skills and adequate knowledge of the medical condition for which medicines are being supplied.

9Stakeholder Engagement & Publicity

The PCT will publicise the contact details of participating pharmacies.

10Quality & Clinical Governance Standards

The pharmacy has appropriate PCT provided patient literature/health promotion and other material available and a suitable area within the pharmacy for display of these materials. The pharmacy can demonstrate how it actively promotes the uptake of these materials.

The pharmacy contractor can demonstrate that pharmacists involved in the provision of the service have undertaken relevant CPD.

The pharmacy participates in audit of service provision at reasonable intervals determined by the PCT. This will include audit of service user experience.

The pharmacy can demonstrate robust quality assurance for any processes or equipment used.

11Service Review

This specification is for the financial year 2010/11 and may be reviewed from time to time if appropriate.

12Exit and Suspension Arrangements

Suspension

The scheme will be suspended if at any time the Provider is unable to provide services in line with the eligibility criteria. Before any suspension the Provider and the Commissioner will discuss the reason for the suspension identifying any possible resolution. If the matter is not resolved the PCT will issue a suspension notice to the Provider within 7 days.

If for any reason, service provision or patient safety is compromised in any way, the contract will be suspended pending the outcome of a full investigation, following which the agreement will either terminate or be reinstated.

Termination

At the point of review, usually annually, either party is entitled to discontinue the service with three months notice from either side.

Furthermore, both parties may terminate the agreement with immediate effect if there has been a breach of contract or insolvency on either party’s part.

Variation

The service may be varied if the Provider and Wakefield District PCT agree this in writing.

13Activity & Costs

The PCT in agreeing to this enhanced service in no way commit themselves to the capital expenditure or revenue consequences of the equipment necessary for particular procedures covered by this enhanced service.

ITEM / PAYMENT
The supply and advise on how to complete the Screening Kits / £5.00 per returned eligible Chlamydia screening specimen where the form contains the relevant pharmacy site code.

Payment will be issued to the Provider(s) on a monthly basis following receipt of a monitoring/evidence form from the Chlamydia Screening Service confirming the number of valid returns. The PCT will make payments on a monthly basis and be identifiable as Local Scheme 8.

14References:

15Signatures

Should the pharmacy wish to undertake theProvision of Chlamydia Screening, through the Community Pharmacy Local Enhanced Service (CPLES), please refer to the Enhanced Services Schedule 2010/2011 for signatures.

Please be aware that in signing the enhanced service schedule 2010/2011 the pharmacy/pharmacist is agreeing to undertake all elements of this enhanced service as detailed in this specification.

COMMUNITY PHARMACY LOCAL ENHANCED SERVICE AGREEMENT 2010/2011

Provision of Chlamydia Screening

Parties to the Agreement:

This agreement is made between:and

Wakefield District PCT ……………………………………...
White Rose House ……………………………………...
West Parade ……………………………………..
Wakefield ……………………………………..
WF1 1LT ……………………………………..

Signed on behalf of WDPCT:

______(Signed)

______(Name)

______(Position)

______(Date)

Signed on behalf of the Provider:

______(Signed)

______(Name)

______(Position)

______(Date)

______(OCS Code)

1

AUTHORISATION OF NAMED HEALTH PROFESSIONAL TO OFFER SERVICES UNDER

COMMUNITY PHARMACY LOCAL ENHANCED SERVICE (CPLES)

The Provision of Chlamydia Screening

Name of Pharmacist/ other accredited staff member / Trading Name of Pharmacy / Pharmacy Address / Signature of Pharmacist / Date / Date CPPE Training
Completed

1

Page 1 of 9